Orchid Pharma Limited (BOM:524372)
India · Delayed Price · Currency is INR 981.90
-27.95 (-2.77%)
At close: Jun 19, 2026
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 49.66 billion as of June 18, 2026. Its market cap has increased by 55.71% in one year.
Market Cap
49.66B
Enterprise Value
52.45B
Revenue
8.11B
Ranking
n/a
PE Ratio
241.67
Stock Price
981.90
Market Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 49.66B, an increase of 6,727.07%. That is a compound annual growth rate of 111.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 49.66B | 29.00% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viyash Scientific | 110.86B |
| Procter & Gamble Health | 104.86B |
| Sanofi India | 77.49B |
| FDC Limited | 62.49B |
| Bliss GVS Pharma | 50.20B |
| Gufic Biosciences | 35.81B |
| Novartis India | 33.71B |
| Unichem Laboratories | 31.59B |